Completed OBSERVATIONAL NCT00046553

Brain Receptor Function in Post-Traumatic Stress Disorder

Glucocorticoid and Mineralocorticoid Receptor Function in Post Traumatic Stress Disorder

Sponsor: National Institute of Mental Health (NIMH)

Conditions Post-Traumatic Stress Disorder

Updated 6 times since 2017 Last updated: Mar 3, 2008 Started: Sep 30, 2002 Completion: Oct 31, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00046553, this observational or N/A phase trial focuses on Post-Traumatic Stress Disorder and remains completed. Sponsored by National Institute of Mental Health (NIMH), it has been updated 6 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Sep 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Mental Health (NIMH)

Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bethesda, United States